These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


531 related items for PubMed ID: 21118358

  • 1. 2009 Japanese Society for Dialysis Therapy guidelines for peritoneal dialysis.
    Working Group Committee for Preparation of Guidelines for Peritoneal Dialysis, Japanese Society for Dialysis Therapy, Japanese Society for Dialysis Therapy.
    Ther Apher Dial; 2010 Dec; 14(6):489-504. PubMed ID: 21118358
    [Abstract] [Full Text] [Related]

  • 2. Multidisciplinary clinical strategies for encapsulating peritoneal sclerosis in peritoneal dialysis: update from Japan.
    Nakayama M, Terawaki H.
    Int J Urol; 2014 Aug; 21(8):755-61. PubMed ID: 24673567
    [Abstract] [Full Text] [Related]

  • 3. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y, Nishi S, Akiba T, Hirakata H, Iseki K, Kubota M, Kuriyama S, Komatsu Y, Suzuki M, Nakai S, Hattori M, Babazono T, Hiramatsu M, Yamamoto H, Bessho M, Akizawa T.
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [Abstract] [Full Text] [Related]

  • 4. Development of a computer-aided diagnosis system for a new modality of renal replacement therapy: an integrated approach combining both peritoneal dialysis and hemodialysis.
    Hamada H, Namoto S, Yamada R, Yamashita AC, Ishizaki M, Okamoto M.
    Comput Biol Med; 2005 Dec; 35(10):845-61. PubMed ID: 16310010
    [Abstract] [Full Text] [Related]

  • 5. [Peritoneal dialysis: a time-limited therapy because of encapsulating peritoneal sclerosis?].
    Bertoli SV, Musetti C.
    G Ital Nefrol; 2010 Dec; 27(5):464-8. PubMed ID: 20922677
    [Abstract] [Full Text] [Related]

  • 6. Successful peritoneal lavage therapy for prevention of encapsulating peritoneal sclerosis: a case report.
    Ubara Y, Tagami T, Hara S.
    Ther Apher Dial; 2011 Apr; 15(2):211-3. PubMed ID: 21426518
    [No Abstract] [Full Text] [Related]

  • 7. Encapsulating peritoneal sclerosis in the era of a multi-disciplinary approach based on biocompatible solutions: the NEXT-PD study.
    Nakayama M, Miyazaki M, Honda K, Kasai K, Tomo T, Nakamoto H, Kawanishi H.
    Perit Dial Int; 2014 Apr; 34(7):766-74. PubMed ID: 24497585
    [Abstract] [Full Text] [Related]

  • 8. Peritoneal dialysis compared with hemodialysis in the treatment of end-stage renal disease.
    Alloatti S, Manes M, Paternoster G, Gaiter AM, Molino A, Rosati C.
    J Nephrol; 2000 Apr; 13(5):331-42. PubMed ID: 11063136
    [Abstract] [Full Text] [Related]

  • 9. [Standard methods of peritoneal dialysis (PD) and standard peritoneal dialysis solutions in the future in Japan].
    Nakamoto H.
    Nihon Jinzo Gakkai Shi; 2009 Apr; 51(7):864-74. PubMed ID: 19928560
    [No Abstract] [Full Text] [Related]

  • 10. Choosing therapy for end-stage renal disease.
    Rosansky SJ.
    Am Fam Physician; 1983 Jul; 28(1):115-24. PubMed ID: 6346843
    [Abstract] [Full Text] [Related]

  • 11. Advances in peritoneal dialysis: a review.
    Bargman JM.
    Semin Dial; 2012 Jul; 25(5):545-9. PubMed ID: 22892042
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Encapsulating Peritoneal Sclerosis.
    Alston H, Fan S, Nakayama M.
    Semin Nephrol; 2017 Jan; 37(1):93-102. PubMed ID: 28153198
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis--a multicentre study in Japan.
    Hirahara I, Inoue M, Okuda K, Ando Y, Muto S, Kusano E.
    Nephrol Dial Transplant; 2007 Feb; 22(2):560-7. PubMed ID: 17035369
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Peritoneal dialysis in patients with diabetic nephropathy].
    Auinger M, Edlinger R, Prager R.
    Wien Klin Wochenschr; 2005 Feb; 117 Suppl 6():29-34. PubMed ID: 16437330
    [Abstract] [Full Text] [Related]

  • 18. [Renal function substitutes. Technical and logistic orientation of the treatment].
    Legrain M, Rottembourg J.
    Ann Med Interne (Paris); 1982 Feb; 133(8):611-24. PubMed ID: 6763488
    [Abstract] [Full Text] [Related]

  • 19. [Peritoneal dialysis: a time-limited therapy because of encapsulating peritoneal sclerosis? No, but better approaches are available].
    Garosi G.
    G Ital Nefrol; 2010 Feb; 27(5):456-63. PubMed ID: 20922676
    [Abstract] [Full Text] [Related]

  • 20. Development of encapsulating peritoneal sclerosis following bacterial peritonitis in a peritoneal dialysis patient.
    Hsu YH, Hsia CC, Tsai DM, Tu HY, Hung KY, Huang JW.
    Am J Kidney Dis; 2010 Jan; 55(1):198-202. PubMed ID: 19782452
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.